Raymond James reiterates Humana stock rating on Q3 beat

Investing.com · 2026-11-06 14:32 UTC

Raymond James reiterates Humana stock rating on Q3 beat

Investing.com - Raymond James reiterated an Outperform rating and $520.00 price target on Humana Inc. (NYSE:HUM) following the company’s third-quarter results.

Humana reported revenue of $41.2 billion for the third quarter of 2026, exceeding the Street estimate of $40.9 billion and Raymond James’ estimate of $40.8 billion. The company posted an adjusted pre-tax loss of $104 million, better than the Street estimate of a $147 million loss and Raymond James’ estimate of a $163 million loss.

The company reported adjusted earnings per share of negative $0.70, beating both the Street and Raymond James estimates of negative $1.00. The insurance segment medical loss ratio came in at 93.7%, below the Street and Raymond James estimates of 94.2%. Despite the quarterly loss, the stock has surged 68% over the past six months, trading at $414.50 with a market capitalization of $49.45 billion.

Read the full story at Investing.com · All coverage of this story